Compounds and their uses
Details for Australian Patent Application No. 2002236521 (hide)
International Classifications
Event Publications
19 April 2007 Application Accepted
Published as AU-B-2002236521
16 August 2007 Standard Patent Sealed
22 January 2009 Assignment Registered
Guilford Pharmaceuticals Inc. The patent has been assigned to MGI GP, Inc.
9 April 2009 Assignment Registered
MGI GP, Inc. The patent has been assigned to Eisai Corporation of North America
10 December 2009 Assignment Registered
Eisai Corporation of North America The patent has been assigned to Eisai Inc.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2002236522-Recombinant RSV virus expression systems and vaccines
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser